Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
27.1M
-
Shares change
-
-364K
-
Total reported value, excl. options
-
$1.74B
-
Value change
-
-$30.5M
-
Put/Call ratio
-
1.26
-
Number of buys
-
108
-
Number of sells
-
-87
-
Price
-
$64.20
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2018
242 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2018.
CONMED Corp - Common Stock (CNMD) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.1M shares
of 30.9M outstanding shares and own 87.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.27M shares), Vanguard Group Inc (2.76M shares), DIMENSIONAL FUND ADVISORS LP (1.64M shares), Capital Research Global Investors (1.52M shares), Champlain Investment Partners, LLC (1.42M shares), STATE STREET CORP (1M shares), SCOPIA CAPITAL MANAGEMENT LP (969K shares), GOLDMAN SACHS GROUP INC (820K shares), MACQUARIE GROUP LTD (807K shares), and NORTHERN TRUST CORP (606K shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.